Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Royalty Pharma

www.royaltypharma.com

Latest From Royalty Pharma

Another Change At Perrigo Helm As Results Remain Turbulent

Incoming CEO Murray Kessler is a seasoned veteran of regulated consumer markets – but not health care. Will his combination of experience and fresh perspective help enable the OTC private label market leader to reverse share declines?

Appointments Prescription To Otc Switch

Another Change At Perrigo Helm As Results Remain Turbulent

Incoming CEO Murray Kessler is a seasoned veteran of regulated consumer markets – but not health care. Will his combination of experience and fresh perspective help enable the OTC private label market leader to reverse share declines?

Appointments Prescription To Otc Switch

Another Change At Perrigo Helm As Results Remain Turbulent

Incoming CEO Murray Kessler is a seasoned veteran of regulated consumer markets – but not health care. Will his combination of experience and fresh perspective help enable the OTC private label market leader to reverse share declines?

Appointments Prescription To Otc Switch

ITBMed Raises $67M To Induce Organ Transplant Tolerance

Swedish biopharma ITBMed has secured $67m to develop siplizumab, its anti-CD2 monoclonal antibody, as an alternative to life-long use of conventional immunosupressants in organ transplant patients.

Commercial Financing
See All

Company Information

  • Industry
  • Miscellaneous
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Royalty Pharma AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Royalty Pharma
  • Senior Management
  • Pablo Legorreta, CEO
    Susannah Gray, EVP, CFO
  • Contact Info
  • Royalty Pharma
    Phone: (41)(212) 883-0200
    110 East 59th St.
    33rd Fl.
    New York, NY 10022
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register